Journal of Thrombosis and Thrombolysis

Công bố khoa học tiêu biểu

* Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp:  
Clinical outcomes after percutaneous coronary intervention for early versus late and very late stent thrombosis: a systematic review and meta-analysis
Journal of Thrombosis and Thrombolysis - Tập 51 - Trang 682-692 - 2020
Yi-Xing Yang, Yin Liu, Xiao-Wei Li, Peng-Ju Lu, Jiao Wang, Chang-Ping Li, Jing Gao
Whether the clinical outcomes of stent thrombosis (ST) are different when stratified by time of occurrence remains unclear. The objective of this study was to compare the short- and long-term clinical outcomes after percutaneous coronary intervention (PCI) for early stent thrombosis (EST) versus late stent thrombosis (LST) and very late stent thrombosis (VLST). We enrolled eligible studies searche...... hiện toàn bộ
Platinoid effects on human plasmatic coagulation kinetics: a viscoelastic analysis
Journal of Thrombosis and Thrombolysis - Tập 51 - Trang 577-583 - 2021
Vance G. Nielsen
In recent years a variety of metals (cadmium, chromium, copper, iron) have been demonstrated to modulate coagulation in vitro and in vivo. One group of metals, the platinoids, have not been assessed, and such investigation is justified given the thromboembolic phenomena associated with platinum-based chemotherapy. Thus, the goal of the present investigation was to assess the effects of carboplatin...... hiện toàn bộ
Selective thromboxane inhibition after vascular protectant AGI-1067: results of assessment of lipoprotein profiles (ALPS) biomarkers in vitro and in vivo substudy
Journal of Thrombosis and Thrombolysis - Tập 27 - Trang 438-446 - 2008
Victor Serebruany, Alex Malinin, Fei-Hua Qiu, X.-C. Xu, Charles Kunsch, Robert Scott
Background Oxidative stress play an important role triggering platelet/endothelial activation. AGI-1067 is a novel, phenolic antioxidant, and vascular protectant which dose-dependently inhibits PEA biomarkers in vitro. Whether treatment with AGI-1067 alters platelets in vivo is not known. We serially assessed release of established PEA biomarkers in subjects treated with AGI-1067 versus placebo in...... hiện toàn bộ
Persistent high on-treatment platelet reactivity in acute coronary syndrome
Journal of Thrombosis and Thrombolysis - Tập 33 - Trang 267-273 - 2012
Donald R. Lynch, Farooq H. Khan, Dhananjay Vaidya, Marlene S. Williams
Persistent high on-treatment platelet reactivity in acute coronary syndrome (ACS) patients managed with appropriate antiplatelet therapy has been correlated with increased risk of cardiovascular events; however, the evolution of this phenomenon overtime is not well known. We investigated platelet activity at a three month follow-up after initial presentation with an ACS. We enrolled a total of 124...... hiện toàn bộ
Transient endothelial injury and release of lupus anticoagulant in COVID-19
Journal of Thrombosis and Thrombolysis - - 2022
Antonin Trimaille, Benjamin Marchandot, Walid Oulehri, Adrien Carmona, Olivier Vollmer, Vincent Poindron, Kensuke Matsushita, Laurent Sattler, Lélia Grunebaum, Anne‐Sophie Korganow, Valérie B. Schini‐Kerth, Olivier Morel
Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation
Journal of Thrombosis and Thrombolysis - Tập 26 - Trang 97-102 - 2007
Mehmet Polatli, Aysel Çakir, Orhan Cildag, A. Zahit Bolaman, Cigdem Yenisey, Yavuz Yenicerioglu
In COPD, the systemic effects of the disease reflect the structural and/or biochemical alterations occurring in the structures or organs other than the lungs in relation to the characteristics of the primary disease. The disorders of endothelial structures due to COPD may lead vascular pathologies, such as ischemic heart disease, stroke, to occur more commonly in those with COPD. On consideration ...... hiện toàn bộ
Architecture of fibrin network inside thrombotic material obtained from the right atrium and pulmonary arteries: flow and location matter
Journal of Thrombosis and Thrombolysis - Tập 35 Số 1 - Trang 127-129 - 2013
Mazur, Piotr, Sobczyński, Robert, Ząbczyk, Michał, Babiarczyk, Paulina, Sadowski, Jerzy, Undas, Anetta
Pulmonary embolectomy is a treatment option in selected patients with high-risk pulmonary embolism (PE). Efficiency of thrombus degradation in PE largely depends on the architecture of its fibrin network, however little is known about its determinants. We present the case of a 56-year-old woman with high-risk PE and proximal deep-vein thrombosis, whose thrombotic material removed during embolectom...... hiện toàn bộ
Optimizing the treatment of unstable angina
Journal of Thrombosis and Thrombolysis - Tập 2 - Trang 205-218 - 1995
Christopher P. Cannon
Unstable angina and non-Q-wave myocardial infarction (MI) are at the center of the spectrum of myocardial ischemia, which ranges from stable angina to acute Q-wave MI. In addition to clinical evaluation, cardiac specific markers such as troponin T or I can assist in early diagnosis, triage, and risk stratification. Antithrombotic therapy with aspirin and heparin have been shown to improve the outc...... hiện toàn bộ
Proceedings of the 11th national conference on anticoagulant therapy: research abstracts
Journal of Thrombosis and Thrombolysis - Tập 31 - Trang 367-400 - 2011
Elizabeth Goldstein
Rescue catheter-based therapies for the treatment of acute massive pulmonary embolism after unsuccessful systemic thrombolysis
Journal of Thrombosis and Thrombolysis - Tập 51 - Trang 805-813 - 2020
Maofeng Gong, Guoping Chen, Boxiang Zhao, Jie Kong, Jianping Gu, Xu He
The management of acute massive pulmonary embolism (PE) patients who did not respond to systemic thrombolysis (ST) has not been well established. The present study aimed to investigate the safety and effectiveness of catheter-based therapies (CDT) in this condition. We conducted a retrospective study of PE patients after unsuccessful ST (UST) between January 2012 and January 2018. Massive PE was i...... hiện toàn bộ
Tổng số: 2,577   
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10